COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer -
COMMUNIQUÉ DE PRESSE
BeWhere Holdings Inc. Announces Expedited Acquisition and Appointment of Board Member
BeWhere Holdings Inc. acquires 100% of a US Corporation for USD600,000 cash and equity. Peter Wilcox appointed to the Board of Directors. Company focuses on mobile IoT solutions for asset tracking and connected sensors -
COMMUNIQUÉ DE PRESSE
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Applied DNA Sciences reschedules Investor Update call to February 13, 2025, coinciding with Q1 fiscal 2025 results release due to National Day of Mourning. Company develops PCR-based technologies -
-
COMMUNIQUÉ DE PRESSE
Blockchain Loyalty Corp., Also Known as Belle Bonica Luxe Corp., May Pursue Legal Action Against its Former Transfer Agent, Legacy Stock Transfer Inc. for Obstruction and Breach of Duty
Blockchain Loyalty Corp. considers legal action against former transfer agent Legacy Stock Transfer for obstructive conduct, breach of fiduciary duty, and misconduct. The company strives for accountability and transparency -
-
-
